Dipeptidyl Peptidase 4 Inhibitors
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 17, 2025

A High-Throughput Luciferase Assay to Evaluate Proteolysis of the Single-Turnover Protease PCSK9
Published on: August 28, 2018
Ulrich Laufs1, Matthias Blüher2, Berend Isermann3
1Klinik und Poliklinik für Kardiologie, University Hospital Leipzig, Liebigstr. 20, 04103 Leipzig, Germany.
No abstract available in PubMed .